AIG
ABUS icon

American International Group’s Arbutus Biopharma ABUS Stock Holding History

American International Group’s Portfolio ABUS Stock Details ABUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-62,439
Closed -$161K – 18
2024
Q1 		$161K Sell
62,439
-536
-0.9% -$1.39K ﹤0.01% 2269
2023
Q4 		$157K Buy
62,975
+683
+1% +$1.34K ﹤0.01% 2299
2023
Q3 		$126K Buy
62,292
+2,214
+4% +$4.64K ﹤0.01% 2374
2023
Q2 		$138K Buy
60,078
+5,246
+10% +$13.7K ﹤0.01% 2381
2023
Q1 		$166K Buy
54,832
+1,091
+2% +$3.08K ﹤0.01% 2220
2022
Q4 		$125K Buy
53,741
+2,472
+5% +$5.91K ﹤0.01% 2401
2022
Q3 		$98K Buy
51,269
+725
+1% +$1.71K ﹤0.01% 2563
2022
Q2 		$137K Buy
50,544
+5,312
+12% +$13.6K ﹤0.01% 2407
2022
Q1 		$135K Buy
45,232
+2,533
+6% +$7.75K ﹤0.01% 2463
2021
Q4 		$166K Sell
42,699
-1,278
-3% -$4.96K ﹤0.01% 2466
2021
Q3 		$189K Buy
43,977
+214
+0.5% +$713 ﹤0.01% 2464
2021
Q2 		$133 Buy
+43,763
New +$136K ﹤0.01% 2755
2019
Q2 		– Sell
-22,516
Closed -$81K – 3102
2019
Q1 		$81K Sell
22,516
-729
-3% -$2.8K ﹤0.01% 2709
2018
Q4 		$89K Sell
23,245
-180
-0.8% -$887 ﹤0.01% 2658
2018
Q3 		$221K Buy
23,425
+423
+2% +$4.2K ﹤0.01% 2362
2018
Q2 		$168K Buy
+23,002
New +$137K ﹤0.01% 2463
2015
Q2 		– Sell
-8,200
Closed -$143K – 5138
2015
Q1 		$143K Buy
8,200
+4,150
+102% +$85K ﹤0.01% 3261
2014
Q4 		$61.4K Buy
4,050
+1,978
+95% +$34.1K ﹤0.01% 3873
2014
Q3 		$43.8K Buy
+2,072
New +$33.8K ﹤0.01% 4033

Other funds holding ABUS

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
WCM
Whitefort Capital Management New York $339M AUM 52.48% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $7.15B AUM 169.27% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
FCM
FourWorld Capital Management New York $196M AUM 42.39% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

American International Group's ABUS Position: Q2 2024 in Review

American International Group sold out of Arbutus Biopharma (ABUS) in Q2 2024, closing a stake of 62,439 shares — an estimated $161K sold.

American International Group first reported a position in ABUS in Q3 2014 and held it in 19 quarters. The position peaked at $221K in Q3 2018. 131 funds tracked by Wall St. Rank hold ABUS as of Q2 2024.

  • American International Group reported no remaining Arbutus Biopharma position as of Q2 2024 after selling out during the quarter.
  • American International Group sold 62,439 Arbutus Biopharma shares in Q2 2024, an estimated $161K.
  • American International Group first reported a position in Arbutus Biopharma in Q3 2014 and held it in 19 quarters.
  • American International Group's Arbutus Biopharma position peaked at $221K in Q3 2018.
  • 131 funds tracked by Wall St. Rank held Arbutus Biopharma as of Q2 2024.

Based on American International Group's 13F filing for Q2 2024, filed 13 Aug 2024.